Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma.
Mender I, Siteni S, Barron S, Flusche AM, Kubota N, Yu C, Cornelius C, Tedone E, Maziveyi M, Grichuk A, Venkateswaran N, Conacci-Sorrell M, Hoshida Y, Kang R, Tang D, Gryaznov S, Shay JW.
Mender I, et al. Among authors: kang r.
Mol Cancer Ther. 2023 Jun 1;22(6):737-750. doi: 10.1158/1535-7163.MCT-23-0039.
Mol Cancer Ther. 2023.
PMID: 37070671
Free PMC article.